A Phase II Study of VEGF Inhibition in Patients with Unilateral Upper Extremity Lymphedema Following Treatment for Cancer
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
No Description Available
Description
No Description Available
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cancer, Unilateral Upper Extremity Lymphedema
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
18 Apr 2024.
Study ID: 1011003558 (0811-15)
